Holiday Hours

With the exception of Inova hospitals, Inova Emergency Care and Inova-GoHealth Urgent Care, all Inova outpatient offices will be closed for the Christmas and New Year's Day holidays – Wednesday, Dec. 25 and Wednesday, Jan. 1.

Some Inova care sites have additional closures for the holidays, which will be noted on the relevant location pages. 

Michael J. Eblan, MD

Michael Eblan, MD

Michael Eblan, MD

Michael J. Eblan, MD

Specialty
Radiation Oncology
Years of Experience
13
Clinical Interests
Brain Cancer/Tumors, Children's Cancer, Gastrointestinal (GI) Cancer, Lung Cancer, Lymphoma
Gender
Male
Locations

8081 Innovation Park Dr
Bldg B
Fairfax, VA 22031

Phone
Fax
571-472-0540

2280 Opitz Blvd
120
Woodbridge, VA 22191

Phone
Fax
703-590-3199

44035 Riverside Pkwy
100
Leesburg, VA 20176

Phone
Fax
703-858-8870

3580 Joseph Siewick Dr
Fairfax, VA 22033

Phone
Fax
703-391-4255
Northern Virginia Radiation Oncology PC

4320 Seminary Rd
Radiation Oncology
Alexandria, VA 22304

Phone
Fax
703-504-7979

About Michael J. Eblan, MD

Dr. Michael J. Eblan is a specialty care physician board certified in radiation oncology at Radiation Oncology Associates, which he joined in 2016. Prior to joining Radiation Oncology Associates, he completed his internal medicine internship and radiation oncology residency at the University of North Carolina at Chapel Hill. There, he served as chief resident, led quality and safety initiatives to improve patient care, and designed prospective clinical investigations of circulating tumor cells as a novel biomarker for radiation treatment response. During his residency, Dr. Eblan also completed additional training in CyberKnife robotic radiosurgery and earned a Lean Six Sigma Yellow Belt certification. Much of his research has focused on the effects of radiation on normal tissues and the development of nanotherapeutics to improve the efficacy of chemoradiotherapy and immunotherapy at the Carolina Center of Cancer Nanotechnology Excellence.

Dr. Eblan is trained in all aspects of radiation oncology and has particular clinical interest in thoracic, gastrointestinal, breast, prostate, brain, head and neck, hematologic, and pediatric malignancies. He is experienced with multiple radiotherapy techniques, including proton beam therapy, volumetric modulated arc therapies, intensity-modulated radiation therapy, stereotactic body radiotherapy, CyberKnife radiosurgery, intraoperative radiotherapy, and prostate and gynecologic brachytherapy, including high-dose-rate brachytherapy. His work has been recognized by the American Society for Radiation Oncology, the American Association for Cancer Research, the Conquer Cancer Foundation and the American Society of Clinical Oncology.

Dr. Eblan grew up in Fairfax County and graduated with distinction as an Echols Scholar from the University of Virginia, receiving dual degrees in biology and economics. He then trained at the National Institutes of Health in Bethesda, MD, through a postbaccalaureate Intramural Research Training Award and published numerous research articles on genetic alterations contributing to human disease, including publication in the New England Journal of Medicine. He received his medical degree from the University of Pennsylvania School of Medicine, where he was awarded the Ruth L. Kirschstein National Research Service Award to study cancer biology and proton radiotherapy.

Research and Publications

View list of publications from Dr. Eblan's research

Medical School
Perelman School of Medicine at the University of Pennsylvania
Internships
University of North Carolina Hospitals
Training Specialty: Internal Medicine
6/24/2011 - 6/23/2012
Residencies
University of North Carolina Hospitals
Training Specialty: Radiation Oncology
7/1/2012 - 6/30/2016

Patient Reviews

About Patient Comments

The Patient Rating score is an average of all responses to physician related questions on our nationally-recognized Press Ganey Patient Satisfaction Survey. Responses are measured on a scale of 1 to 5, with 5 being the best score. Comments are gathered from our Press Ganey Patient Satisfaction Survey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.